OneMedNet Corp - Class A Common Stock (ONMD)
Industrials › Services-Commercial Physical & Biological Research
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -59.7%
- Revenue growing at 111% annually
OneMedNet Corp - Class A Common Stock (ONMD) is a Industrials company operating in Services-Commercial Physical & Biological Research, listed on the NASDAQ , with a market capitalisation of $42 million . Key value metrics: Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 4 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
OneMedNet Corp - Class A Common Stock — Fundamental Analysis Summary
On financial health, ONMD shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -59.7% (sector average: 5.4%).
StockPik's composite Value Score for ONMD is 25/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ONMD reports a thin gross margin of -188.8% (sector average: 18.0%) and a negative operating margin of -1,606.0%.
ONMD shows revenue growing at 111% year-over-year, with earnings growing at 72%.